Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Anti Metabolites as the Highest Value Sector by 2017

Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Anti Metabolites as the Highest Value Sector by 2017

Ratings: (0)|Views: 12|Likes:
Published by linda3395
This report provides insight about immunomodulators sales forecasts until 2017. Immunomodulators markets in the key geographies of the US, Europe and other relevant regions are also covered in the report, as are immunomodulators R&D pipelines. The report provides in-depth analysis and market forecasts of the major drug classes, which include immunosuppressants (antibodies, interferon beta, glucocorticoids, calcineurin inhibitors, and antimetabolites), and immunostimulants (antibodies, interferon alpha and vaccines). The report also explores the competitive landscape, with a competitive analysis of the top companies in the market.
This report provides insight about immunomodulators sales forecasts until 2017. Immunomodulators markets in the key geographies of the US, Europe and other relevant regions are also covered in the report, as are immunomodulators R&D pipelines. The report provides in-depth analysis and market forecasts of the major drug classes, which include immunosuppressants (antibodies, interferon beta, glucocorticoids, calcineurin inhibitors, and antimetabolites), and immunostimulants (antibodies, interferon alpha and vaccines). The report also explores the competitive landscape, with a competitive analysis of the top companies in the market.

More info:

Categories:Types, Research
Published by: linda3395 on Feb 01, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

05/13/2014

pdf

text

original

 
 
Immunomodulators Market to 2017 - Immunosuppressant Antibodies to ReplaceAntimetabolites as the Highest Value Sector by 2017
 
Immunosuppressants holds a 64% Market Share of the ImmunomodulatorsMarket with More Products in the Pipeline than Immunostimulants
 This report provides insight about immunomodulators sales forecasts until 2017.Immunomodulators markets in the key geographies of the US, Europe and other relevantregions are also covered in the report, as are immunomodulators R&D pipelines. The reportprovides in-depth analysis and market forecasts of the major drug classes, which includeimmunosuppressants (antibodies, interferon beta, glucocorticoids, calcineurin inhibitors, andantimetabolites), and immunostimulants (antibodies, interferon alpha and vaccines). Thereport also explores the competitive landscape, with a competitive analysis of the topcompanies in the market.GBI Research analysis estimated the global immunomodulators market to be valued at$145.9 billion in 2010, with a Compound Annual Growth Rate (CAGR) of 13.1% between2002 and 2010. The market is forecast to grow at a CAGR of 8.6% between 2010 and 2017,to reach $259.3 billion in 2017. In-depth analysis in the report is based on proprietydatabases, primary and secondary research and in
house analysis by the GBI Researchteam of experts.GBI Research analysis found the R&D pipeline for the immunomodulators market to bestrong. Many of the major pharmaceutical companies such as Roche, Amgen, and Johnson & Johnson are expanding into this market. This indicates that R&D activity forimmunomodulators will remain active for at least next four to five years.
Request a Sample for or Inquire before buying the report 
 
 Published:
February 2012
No.OF Pages:
290
 Price: Single User License
US$ 3500
Corporate User License
US$ 10500
 
Scope
 * Data and analysis of the immunomodulators market in the leading geographies of the USand Europe. Different drug classes of immunomodulators discussed in the report areimmunosuppressants (antibodies, interferon beta, glucocorticoids, calcineurin inhibitors,antimetabolites) and immunostimulants (antibodies, interferon alpha and vaccines).* Annualized market data for the immunomodulators market from 2002 to 2010, with
 
 
forecasts to 2017.* Market data on the geographical landscape and therapeutic landscape, including marketsizes, market shares, annual costs of therapy and sales volumes* Key drivers and restraints that have had significant impact on the market.* Competitive landscape of the global immunomodulators market including benchmarking of the top companies. The key companies studied in this report are Hoffman La Roche, Amgen,Abbott, Johnson & Johnson, Novartis, Biogen Idec, Merck, Bristol-Myers Squibb, Eli Lilly.
Reasons to buy
 * Build effective strategies to launch pipeline products, by identifying potential geographies.* Exploit in-licensing and out-licensing opportunities by identifying products to fill theirportfolio gaps.* Develop key strategic initiatives by studying the key strategies of the top competitors.* Develop market-entry and market expansion strategies, by identifying the geographicmarkets poised for strong growth.* Reinforce R&D pipelines by identifying new target mechanisms which can produce first
in-class molecules with improved efficacy and safety profiles.
Major points covered in Table of Contents of this report include:
 
1 Table of Contents2 Immunomodulators Market to 2017 - Market Introduction3 Immunomodulators Market to 2017 - Market Characterization4 Immunomodulators Market to 2017 - Geographical Landscape5 Immunomodulators Market to 2017 - Immunosuppressants6 Immunosuppressants - Antibodies7 Immunosuppressants - Interferon Beta8 Immunosuppressants - Glucocorticoids9 Immunosuppressants - Calcineurin Inhibitors10 Immunosuppressants - Antimetabolites11 Immunomodulators Market to 2017 - Immunostimulants12 Immunostimulants - Vaccines, Active Immunity13 Immunostimulants: Antibodies - Passive Immunity14 Immunostimulants: Interferon Alpha - Passive Immunity

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->